Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on April 1, 2025

Vertical Flight Society Announces 2025 Scholarship Recipients

Vertical Flight Society Announces 2025 Scholarship Recipients

Scholarships totaling a record $126,000 awarded to 33 engineering students interested in vertical flight from schools across North America, Europe and Asia. FAIRFAX, VA, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- The Vertical Flight Society is …

CDC Layoffs Deliver Devastating Blow to Respiratory Health

CDC Layoffs Deliver Devastating Blow to Respiratory Health

Washington, DC, April 01, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is deeply concerned about recent reductions in force (RIFs) at the Centers for Disease Control and Prevention (CDC), which put critical public health …

Cygnus secures another two years to increase its stake in Pontax

Cygnus secures another two years to increase its stake in Pontax

Pontax Lithium Project, James Bay, Canada TORONTO and PERTH, Western Australia, April 01, 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5, TSXV: CYG, OTCQB: CYGGF) is pleased to announce that it has negotiated a two-year extension to its two-stage …

Cygnus bénéficie de deux années supplémentaires pour accroître sa participation dans Pontax

Cygnus bénéficie de deux années supplémentaires pour accroître sa participation dans Pontax

Projet de lithium Pontax, Baie James, Canada TORONTO et PERTH, Australie-Occidentale, 01 avr. 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5, TSXV: CYG, OTCQB: CYGGF) est heureuse d'annoncer qu'elle a négocié une prolongation de deux ans de son …

HNF-Funded Wearable Sensor Study to Be Presented at the 2025 AAN Annual Meeting

HNF-Funded Wearable Sensor Study to Be Presented at the 2025 AAN Annual Meeting

HNF remains dedicated to funding and supporting innovative research efforts that improve the lives of those living with CMT and other neuromuscular disorders. NEW YORK, NY, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- The Hereditary Neuropathy …

NowVertical Reports Record 2024 Financial Results

NowVertical Reports Record 2024 Financial Results

Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …

Volatus Aerospace to Present at the AI & Technology Virtual Investor Conference on April 3rd

Volatus Aerospace to Present at the AI & Technology Virtual Investor Conference on April 3rd

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (OTCQX: TAKOF) (TSXV: FLT) (Frankfurt: ABB), a leader in innovative aerial solutions, invites individual and institutional investors, as well as analysts and advisors, to join the AI …

Volatus Aerospace présentera à la conférence virtuelle des investisseurs en IA et technologies le 3 avril

Volatus Aerospace présentera à la conférence virtuelle des investisseurs en IA et technologies le 3 avril

TORONTO, 01 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (OTCQX : TAKOF) (TSXV : FLT) (Frankfurt : ABB), un leader dans les solutions aériennes innovantes, invite les investisseurs institutionnels et individuels, ainsi que les analystes et …

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces …

HCW Biologics Announces 1-for-40 Reverse Stock Split

HCW Biologics Announces 1-for-40 Reverse Stock Split

MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the role of the test in prompting use of …

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement  of approximately …

nCino Reports Fourth Quarter and Fiscal Year 2025 Financial Results

nCino Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Q4 Total Revenues of $141.4M, up 14% year-over-year Fiscal Year 2025 Total Revenues of $540.7M, up 13% year-over-year Q4 Subscription Revenues of $125.0M, up 16% year-over-year Fiscal Year 2025 Subscription Revenues of $469.2M, up 15% year-over-year …

Jamf completes acquisition of Identity Automation, expanding its platform to include dynamic identity management for specific industries

Jamf completes acquisition of Identity Automation, expanding its platform to include dynamic identity management for specific industries

MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced it has completed the acquisition of Identity Automation, a dynamic identity and access management (IAM) platform for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service